Market cap CAGR of biotech companies in the U.S. 2012-2016
This statistic displays the CAGR of selected biotechnology companies' market capitalization in the United States between 2012 and 2016. During this period, Amgen had a CAGR of 21 percent. Revenues of the United States' biotechnology market has grown over the last 15 years.